Illumina Clinical Services is a company within the Biotechnology category. Illumina Clinical Services is the clinical laboratory and professional services arm of Illumina, Inc. It provides CLIA-certified, CAP-accredited genomic testing and interpretation services, specifically focusing on whole-genome sequencing for rare and undiagnosed diseases. The division bridges the gap between Illumina's sequencing technology and the specialized needs of healthcare providers and patients.
Illumina Clinical Services was founded in 1998 and is headquartered in San Diego, CA.
Illumina Clinical Services is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Illumina Clinical Services is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify Illumina Clinical Services as a Challenger. AI names competitors first.
Illumina Clinical Services appeared in 5 of 8 sampled buyer-intent queries (63%). While Illumina is the top result for 'DNA sequencing,' it often loses the 'Services' queries to specialized clinical diagnostic labs like Quest or Invitae.
Illumina Clinical Services is consistently recognized as the service-oriented branch of the market-leading genomics company. While its connection to the parent is clear, AI often fails to distinguish its specific clinical lab offerings from the broader corporate hardware business. Key gap: AI often confuses the 'Clinical Services' laboratory division with Illumina's software platforms (like ICA) or its hardware products (NovaSeq).
Of 5 key facts verified about Illumina Clinical Services, 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The distinction between Illumina as a manufacturer (selling kits) and Illumina as a service provider (performing the tests) is frequently blurred in AI summaries.
Buyers turn to Illumina Clinical Services for In-house Clinical Interpretation: Physicians or genetic counselors manually interpreting lab results using clinical databases and literature., External Genetic Consultancy: Engaging specialized tertiary genomic analysis firms or academic medical centers for case review., Do Nothing / Status Quo: Continuing with standard-of-care diagnostic protocols without integrated genomic insights., among 3 documented problem areas.
Buyers evaluating Illumina Clinical Services typically ask AI models about "whole genome sequencing clinical services", "CLIA certified sequencing labs for rare disease", "genetic counseling for undiagnosed diseases service providers", and 3 similar queries.
Illumina Clinical Services's core products are Clinical Whole Genome Sequencing (cWGS), genetic counseling, clinical interpretation services..
Illumina Clinical Services uses Enterprise/Custom.
Illumina Clinical Services serves Hospitals, biopharma companies, research institutions, and individual physicians..
Illumina Clinical Services Direct vertical integration with the world's leading sequencing technology manufacturer, providing faster access to the latest genomic advancements.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/illumina-clinical-services
Last analyzed: April 10, 2026
Founded: 1998 (Parent company)
Headquarters: San Diego, CA